Cargando…

Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation

Context: Alismatis rhizome decoction (AD) exhibits antiatherosclerotic activities. The activity of AD against vascular smooth muscle cell (VSMC) proliferation remains unclear. Objective. The mechanisms and effects of AD on oxidized low-density lipoprotein (ox-LDL)-induced VSMC proliferation were exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Julian, Wei, Wei, Wang, Xialei, Yang, Jingda, Lu, Lu, Lv, Xinru, Xue, Xiehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463403/
https://www.ncbi.nlm.nih.gov/pubmed/32908568
http://dx.doi.org/10.1155/2020/7275246
_version_ 1783577123980574720
author Shen, Julian
Wei, Wei
Wang, Xialei
Yang, Jingda
Lu, Lu
Lv, Xinru
Xue, Xiehua
author_facet Shen, Julian
Wei, Wei
Wang, Xialei
Yang, Jingda
Lu, Lu
Lv, Xinru
Xue, Xiehua
author_sort Shen, Julian
collection PubMed
description Context: Alismatis rhizome decoction (AD) exhibits antiatherosclerotic activities. The activity of AD against vascular smooth muscle cell (VSMC) proliferation remains unclear. Objective. The mechanisms and effects of AD on oxidized low-density lipoprotein (ox-LDL)-induced VSMC proliferation were explored. Materials and methods. The male SD rats were fed with AD (2.56 g/mL) or 0.9% NaCl by oral gavage 4 mL twice daily for 7 d. Then, AD-containing serum (ADcs) was collected. MTS assay was applied to measure the VSMC viability. The proliferation of VSMCs was detected by 5-bromodeoxyuridine (BrdU) immunocytochemistry. The microRNA (miRNA) profiling was performed, and the target genes of miRNAs were searched from the TargetScan 7.2 database. The expressions of matrix metalloproteinases-2/9 (MMP-2/9), cyclin D1/E, cyclin-dependent kinase inhibitor 1B (p27), extracellular regulated protein kinases 1/2 (ERK1/2), and ERK1/2 phosphorylation were examined by western blotting or quantitative reverse transcription PCR. Results. The ox-LDL-induced miR-17-92a expression promoted VSMC proliferation. AD and the ERK1/2 inhibitor U0126 (10 μmol/L) inhibited VSMC proliferation and reduced the overexpression of miR-17∼92a. AD was found to inhibit phosphorylation of ERK1/2 and reduced the expression of MMP-2/9 in VSMCs. The expression of cyclin D1/E was suppressed, and p27 was elevated following treatment with AD as well as ERK1/2 inhibitor. According to the TargetScan 7.2 database, the target genes of miR-17∼92a act on tissue inhibitors of metalloproteinases (TIMPs)-MMPs, p27/21 cyclins, and peroxisome-proliferator-activated receptor α (PPARα) ATP-binding cassette transporter (ABC) A1/G1, which are involved in the process of atherosclerosis. Conclusions. AD inhibits ox-LDL-induced VSMC proliferation via inhibiting ERK1/2 and miR-17∼92a activation. The results provide the multitarget mechanisms for application of AD in the treatment of atherosclerosis. It would be helpful to the treatment of cardiovascular and cerebral diseases.
format Online
Article
Text
id pubmed-7463403
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74634032020-09-08 Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation Shen, Julian Wei, Wei Wang, Xialei Yang, Jingda Lu, Lu Lv, Xinru Xue, Xiehua Evid Based Complement Alternat Med Research Article Context: Alismatis rhizome decoction (AD) exhibits antiatherosclerotic activities. The activity of AD against vascular smooth muscle cell (VSMC) proliferation remains unclear. Objective. The mechanisms and effects of AD on oxidized low-density lipoprotein (ox-LDL)-induced VSMC proliferation were explored. Materials and methods. The male SD rats were fed with AD (2.56 g/mL) or 0.9% NaCl by oral gavage 4 mL twice daily for 7 d. Then, AD-containing serum (ADcs) was collected. MTS assay was applied to measure the VSMC viability. The proliferation of VSMCs was detected by 5-bromodeoxyuridine (BrdU) immunocytochemistry. The microRNA (miRNA) profiling was performed, and the target genes of miRNAs were searched from the TargetScan 7.2 database. The expressions of matrix metalloproteinases-2/9 (MMP-2/9), cyclin D1/E, cyclin-dependent kinase inhibitor 1B (p27), extracellular regulated protein kinases 1/2 (ERK1/2), and ERK1/2 phosphorylation were examined by western blotting or quantitative reverse transcription PCR. Results. The ox-LDL-induced miR-17-92a expression promoted VSMC proliferation. AD and the ERK1/2 inhibitor U0126 (10 μmol/L) inhibited VSMC proliferation and reduced the overexpression of miR-17∼92a. AD was found to inhibit phosphorylation of ERK1/2 and reduced the expression of MMP-2/9 in VSMCs. The expression of cyclin D1/E was suppressed, and p27 was elevated following treatment with AD as well as ERK1/2 inhibitor. According to the TargetScan 7.2 database, the target genes of miR-17∼92a act on tissue inhibitors of metalloproteinases (TIMPs)-MMPs, p27/21 cyclins, and peroxisome-proliferator-activated receptor α (PPARα) ATP-binding cassette transporter (ABC) A1/G1, which are involved in the process of atherosclerosis. Conclusions. AD inhibits ox-LDL-induced VSMC proliferation via inhibiting ERK1/2 and miR-17∼92a activation. The results provide the multitarget mechanisms for application of AD in the treatment of atherosclerosis. It would be helpful to the treatment of cardiovascular and cerebral diseases. Hindawi 2020-08-22 /pmc/articles/PMC7463403/ /pubmed/32908568 http://dx.doi.org/10.1155/2020/7275246 Text en Copyright © 2020 Julian Shen et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shen, Julian
Wei, Wei
Wang, Xialei
Yang, Jingda
Lu, Lu
Lv, Xinru
Xue, Xiehua
Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation
title Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation
title_full Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation
title_fullStr Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation
title_full_unstemmed Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation
title_short Proliferation of Vascular Smooth Muscle Cells under ox-LDL Is Regulated by Alismatis rhizoma Decoction via InhibitingERK1/2 and miR-17∼92a Cluster Activation
title_sort proliferation of vascular smooth muscle cells under ox-ldl is regulated by alismatis rhizoma decoction via inhibitingerk1/2 and mir-17∼92a cluster activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463403/
https://www.ncbi.nlm.nih.gov/pubmed/32908568
http://dx.doi.org/10.1155/2020/7275246
work_keys_str_mv AT shenjulian proliferationofvascularsmoothmusclecellsunderoxldlisregulatedbyalismatisrhizomadecoctionviainhibitingerk12andmir1792aclusteractivation
AT weiwei proliferationofvascularsmoothmusclecellsunderoxldlisregulatedbyalismatisrhizomadecoctionviainhibitingerk12andmir1792aclusteractivation
AT wangxialei proliferationofvascularsmoothmusclecellsunderoxldlisregulatedbyalismatisrhizomadecoctionviainhibitingerk12andmir1792aclusteractivation
AT yangjingda proliferationofvascularsmoothmusclecellsunderoxldlisregulatedbyalismatisrhizomadecoctionviainhibitingerk12andmir1792aclusteractivation
AT lulu proliferationofvascularsmoothmusclecellsunderoxldlisregulatedbyalismatisrhizomadecoctionviainhibitingerk12andmir1792aclusteractivation
AT lvxinru proliferationofvascularsmoothmusclecellsunderoxldlisregulatedbyalismatisrhizomadecoctionviainhibitingerk12andmir1792aclusteractivation
AT xuexiehua proliferationofvascularsmoothmusclecellsunderoxldlisregulatedbyalismatisrhizomadecoctionviainhibitingerk12andmir1792aclusteractivation